Total Return chart Caliway Biopharmaceuticals Co., Ltd.

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
486 ^TWD	+0.41%		+8.00%	+154.12%

05-13	Caliway Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Caliway Biopharmaceuticals Co., Ltd. Announces CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.